Showing 2351-2360 of 2705 results for "".
- Curtis Cluff Named President and CFO of BioPhotas Inc.https://modernaesthetics.com/news/curtis-cluff-named-president-and-cfo-of-biophotas-inc/2473313/Curtis Cluff is the new President and Chief Financial Officer BioPhotas Inc., manufacturers of the Celluma series of light therapy devices. In this newly created role, Mr. Cluff will report to Patrick Johnson, Chief Executive Officer and inventor of the Celluma. &quo
- New Indications for SkinPen in the EU and UKhttps://modernaesthetics.com/news/new-indications-for-skinpen-in-the-eu-and-uk/2473310/Crown Aesthetics’ SkinPen Precision scored three new approved indications in the EU and UK. The new&
- New Research Highlights the Efficacy and Safety Profile of Revance's DAXXIFYhttps://modernaesthetics.com/news/new-research-highlights-the-efficacy-and-safety-profile-of-revances-daxxify/2473304/Two new studies highlight the efficacy and safety profile of Revance Therapeutics, Inc.’s newly approved DAXXIFY (DaxibotulinumtoxinA-lanm). Glabellar injection of DAXXIFY showed a positive effect on eyebrow position, with a modest reduction in forehead muscle activity in&nbs
- BuildMyHealth Names First Chief Revenue Officerhttps://modernaesthetics.com/news/buildmyhealth-points-first-chief-revenue-officer/2473302/BuildMyHealth, developer of the No Surprises Act price transparency and lead conversion platform, has its first Chief Revenue Officer. Chad Sawyer was previously a national sales executive with both Crystal Clear Digital Marketing and Patient Now. In those roles, Mr. Sawyer helped hundreds of pra
- BTL Introduces EMFACEhttps://modernaesthetics.com/news/btl-introduces-emface/2473301/BTL is taking on the minimally invasive facial aesthetic category with the launch of EMFACE. Emface simultaneously emits both
- BeautyHealth’s Hydrafacial Partners with Organicell for Exosome Boosterhttps://modernaesthetics.com/news/beautyhealths-hydrafacial-partners-with-organicell-for-exosome-booster/2473300/The Beauty Health Company is joining forces with biotech company Organicell to co-create a first-to-market exosome booster that will address signs of aging and inflammation in the skin for Hydrafacial. “We are excited to begin development with Organicell to co-create a potentially
- Early Postop Microneedling May Improve Surgical Scarshttps://modernaesthetics.com/news/early-postop-microneedling-may-improve-surgical-scars/2473298/Postsurgical scars treated with minimally invasive percutaneous collagen induction in the maturation and remodeling phase may have better aesthetic outcomes, according to a study published in the September issue of Plastic and Reconstructive Surgery. When treatment is
- Revision Skincare, RVL Pharmaceuticals Form Partnershiphttps://modernaesthetics.com/news/revision-skincare-rvl-pharmaceuticals-form-partnership/2473288/Revision Skincare® is partnering with RVL Pharmaceuticals, Inc. the owner of UPNEEQ®, to collaborate on a variety of marketing efforts within the medical aesthetics industry, working together to address significant unmet consumer needs. Revisions says that, with shared
- 50/50 Women on Boards Lauds Cutera for Gender-Balanced Board of Directorshttps://modernaesthetics.com/news/5050-women-on-boards-lauds-cutera-for-gender-balanced-board-of-directors/2473286/The 50/50 Women on Boards recognized Cutera for having a gender-balanced board. With four women directors, holding 50 percent of its corporate board seats, Cutera, Inc. is one of only 8 percent (just 241) of Russell 3000 companies with a gender-balanced board. &ldq
- Survey Seeks Input on Price Transparency and Surprise Medical Billshttps://modernaesthetics.com/news/survey-seeks-input-on-price-transparency-and-surprise-medical-bills/2473283/To better understand healthcare providers’ views on price transparency, surprise medical bills, and the No Surprises Act a new survey is being fielded. Results of the brief, 4-minute, online survey will be publis